2021
DOI: 10.26650/istanbuljpharm.2020.0056
|View full text |Cite
|
Sign up to set email alerts
|

Bioavailability of berberine: challenges and solutions

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 14 publications
(7 citation statements)
references
References 16 publications
0
6
0
1
Order By: Relevance
“…Several studies showed that berberine had low toxic effects on human beings. For example, a phase I clinical trial showed that berberine was safe at excessive doses [ 134 ]. Another study found that berberine showed low toxicity towards healthy cells [ 135 ].…”
Section: Safety Of Berberinementioning
confidence: 99%
“…Several studies showed that berberine had low toxic effects on human beings. For example, a phase I clinical trial showed that berberine was safe at excessive doses [ 134 ]. Another study found that berberine showed low toxicity towards healthy cells [ 135 ].…”
Section: Safety Of Berberinementioning
confidence: 99%
“…The measurement of the bioavailability of any molecule is often calculated through its pharmacokinetic profile, which includes absorption, metabolism, biodistribution, and elimination (excretion). As Berberine is poorly absorbed and quickly eliminated from the body due to low bioavailability, high doses of Berberine need to be administered to achieve the therapeutic effects [ 52 ]. This reduction in bioavailability is further enhanced due to its binding with plasma proteins; eventually, only the fraction of unbounded Berberine is left to reach the target tissues [ 53 , 54 , 55 , 56 ].…”
Section: Berberinementioning
confidence: 99%
“…Similarly, dendrimers [ 140 ], nanogels [ 141 ], chitosan [ 142 ], and all other polymeric-based nanoparticle carriers were also shown to improve Berberine’s pharmacokinetics. Further, as discussed above, combining different anticancer therapies offers the advantages of using lower drug doses along with a better therapeutic outcome [ 52 ]. Other than the above-stated treatment options, utilizing the strong absorption in the blue wavelength region, Berberine can also be investigated as a potent chemo-photosensitizing agent against localized lung tumor mass.…”
Section: Limitations and Future Perspectivementioning
confidence: 99%
“…Sinh khả dụng đường uống của berberin rất thấp (khoảng 5%) và được phân loại thuộc nhóm IV trong bảng phân loại BCS [8]. Do vậy, để cải thiện độ tan và tính thấm nhằm nâng cao sinh khả dụng của berberin một số dạng bào chế mới đã được triển khai như hệ nano mang thuốc, liposome, micell và phức hợp với phospholipid [9]. Trong nước, một số hệ có kích thước nano với berberin cũng đã được nghiên cứu như liposome, nano berberin [10][11][12].…”
Section: Mở đầU *unclassified